Plasminogen Activator Inhibitor-1 4G/5G Promoter Polymorphism in Indian Patients with Deep Vein Thrombosis

Overview

Journal Indian J Hematol Blood Transfus

Specialty Hematology

Date 2024 May 6

PMID 38708166

Authors

Saniya Sharma

Manu Jamwal

Varun Uppal

Hari Kishan Senee

Manav Jindal

Jasmina Ahluwalia

Reena Das

Neelam Varma

Pankaj Malhotra

Narender Kumar

Affiliations

Soon will be listed here.

Abstract

Supplementary Information: The online version contains supplementary material available at 10.1007/s12288-023-01660-3.

References

Hooper W, Lally C, Austin H, Renshaw M, Dilley A, Wenger N . The role of the t-PA I/D and PAI-1 4G/5G polymorphisms in African-American adults with a diagnosis of myocardial infarction or venous thromboembolism. Thromb Res. 2000; 99(3):223-30. DOI: 10.1016/s0049-3848(00)00236-x. View

Incalcaterra E, Meli F, Muratori I, Corrado E, Amato C, Canino B . Residual vein thrombosis and onset of post-thrombotic syndrome: influence of the 4G/5G polymorphism of plasminogen activator inhibitor-1 gene. Thromb Res. 2014; 133(3):371-4. DOI: 10.1016/j.thromres.2013.12.032. View

Mansilha A, Araujo F, Severo M, Sampaio S, Toledo T, Albuquerque R . Genetic polymorphisms and risk of recurrent deep venous thrombosis in young people: prospective cohort study. Eur J Vasc Endovasc Surg. 2005; 30(5):545-9. DOI: 10.1016/j.ejvs.2005.05.038. View

Akar N, Yilmaz E, Akar E, Avcu F, Yalcin A, Cin S . Effect of plasminogen activator inhibitor-1 4G/5G polymorphism in Turkish deep vein thrombotic patients with and without FV1691 G-A. Thromb Res. 2000; 97(4):227-30. DOI: 10.1016/s0049-3848(99)00164-4. View

Giurgea G, Brunner-Ziegler S, Jilma B, Sunder-Plassmann R, Koppensteiner R, Gremmel T . Plasminogen activator inhibitor-1 4G/5G genotype and residual venous occlusion following acute unprovoked deep vein thrombosis of the lower limb: A prospective cohort study. Thromb Res. 2017; 153:71-75. DOI: 10.1016/j.thromres.2017.03.017. View

Vuckovic B, Djeric M, Tomic B, Djordjevic V, Bajkin B, Mitic G . Influence of decreased fibrinolytic activity and plasminogen activator inhibitor-1 4G/5G polymorphism on the risk of venous thrombosis. Blood Coagul Fibrinolysis. 2017; 29(1):19-24. DOI: 10.1097/MBC.0000000000000656. View

Sciacca F, Ciusani E, Silvani A, Corsini E, Frigerio S, Pogliani S . Genetic and plasma markers of venous thromboembolism in patients with high grade glioma. Clin Cancer Res. 2004; 10(4):1312-7. DOI: 10.1158/1078-0432.ccr-03-0198. View

Hosseini S, Kalantar E, Hosseini M, Tabibian S, Shamsizadeh M, Dorgalaleh A . Genetic risk factors in patients with deep venous thrombosis, a retrospective case control study on Iranian population. Thromb J. 2015; 13:35. PMC: 4640381. DOI: 10.1186/s12959-015-0064-y. View

Prabhudesai A, Shetty S, Ghosh K, Kulkarni B . Investigation of Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G promoter polymorphism in Indian venous thrombosis patients: A case-control study. Eur J Haematol. 2017; 99(3):249-254. DOI: 10.1111/ejh.12912. View

10.

Sartori M, Danesin C, Saggiorato G, Tormene D, Simioni P, Spiezia L . The PAI-1 gene 4G/5G polymorphism and deep vein thrombosis in patients with inherited thrombophilia. Clin Appl Thromb Hemost. 2003; 9(4):299-307. DOI: 10.1177/107602960300900405. View

11.

Segui R, Estelles A, Mira Y, Espana F, Villa P, Falco C . PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects. Br J Haematol. 2000; 111(1):122-8. DOI: 10.1046/j.1365-2141.2000.02321.x. View

12.

Akhter M, Biswas A, Ranjan R, Meena A, Yadav B, Sharma A . Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is seen in higher frequency in the Indian patients with deep vein thrombosis. Clin Appl Thromb Hemost. 2009; 16(2):184-8. DOI: 10.1177/1076029609333673. View

13.

Farajzadeh M, Bargahi N, Zonouzi A, Farajzadeh D, Pouladi N . Polymorphisms in thrombophilic genes are associated with deep venous thromboembolism in an Iranian population. Meta Gene. 2015; 2:505-13. PMC: 4287852. DOI: 10.1016/j.mgene.2014.06.004. View

14.

Sundquist K, Wang X, Svensson P, Sundquist J, Hedelius A, Lonn S . Plasminogen activator inhibitor-1 4G/5G polymorphism, factor V Leiden, prothrombin mutations and the risk of VTE recurrence. Thromb Haemost. 2015; 114(6):1156-64. DOI: 10.1160/TH15-01-0031. View